Aerpio Pharmaceuticals, Inc.
ARPO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$17,746 | -$52,615 | $73,016 | -$14,493 |
| Dep. & Amort. | -$755 | $2 | $19 | -$1,787 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,718 | $3,087 | $1,680 | $10,094 |
| Change in WC | -$733 | $0 | $0 | $0 |
| Other Non-Cash | $1,138 | -$3,431 | -$86,579 | -$14,047 |
| Operating Cash Flow | -$15,378 | -$52,957 | -$11,864 | -$20,233 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$1 | -$551 | $4,090 |
| Net Acquisitions | -$101,356 | $0 | $0 | $0 |
| Inv. Purchases | -$93,555 | -$32,215 | $0 | -$36,482 |
| Inv. Sales/Matur. | $1,998 | $3,390 | $14,693 | $63,338 |
| Other Inv. Act. | $101,286 | $0 | $101,356 | $0 |
| Investing Cash Flow | -$91,627 | -$28,826 | $115,498 | $30,946 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $100,002 | $0 |
| Stock Repurch. | $0 | $24 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$850 | $95,201 | -$53,901 |
| Financing Cash Flow | $0 | -$850 | $95,201 | -$53,901 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$107,005 | -$82,633 | $198,835 | -$1,048 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $144,936 | $227,569 | $28,734 | $29,782 |
| End Cash | $37,931 | $144,936 | $227,569 | $28,734 |
| Free Cash Flow | -$15,378 | -$52,958 | -$12,415 | -$16,143 |